Comprehensive Guide to Bipolar Disorder Management
E N D
Presentation Transcript
Chapter 14 Bipolar Disorders
Clinical Picture • Bipolar I Disorder • Bipolar II Disorder • Cyclothymia
Epidemiology Lifetime prevalence of bipolar disorder in the United States is 3.9% • Bipolar I– more common in males • Bipolar II– more common in females • Cyclothymia – usually begins in adolescence or early adulthood
Etiology • Biological factors • Genetic • Neurobiological • Neuroendocrine • Psychological factors • Environmental factors
Assessment • Mood • Behavior • Thought processes and speech patterns • Flight of ideas • Clag associations • Grandiosity • Cognitive functioning
Self-Assessment • Manic patient • Manipulative • Aggressively demanding • Splitting • Staff member actions • Frequent staff meetings to deal with patient behavior and staff response • Set limits consistently
Assessment Guidelines Bipolar Disorder Danger to self or others Need for protection from uninhibited behaviors Need for hospitalization Medical status Coexisting medical conditions Family’s understanding
Nursing Diagnosis • Risk for injury • Risk for violence • Other-directed • Self-directed • Risk for suicide
Outcomes Identification • Acute phase • Prevent injury • Continuation phase • Relapse prevention • Maintenance phase
Planning • Acute phase • Medical stabilization • Maintaining safety • Self-care needs • Continuation phase • Maintain medication adherence • Psychoeducational teaching • Referrals • Maintenance phase • Prevent relapse
Implementation • Acute phase – highest priority is always safety • Depressive episodes • Manic episodes • Continuation phase • Prevent relapse with follow-up care • Maintenance phase
Pharmacological Interventions • Lithium carbonate • Indications • Therapeutic and toxic levels • Therapeutic blood level 0.8 to 1.4 mEq/L • Maintenance blood level 0.4 to 1.3 mEq/L • Toxic blood level: 1.5 to 2.0 mEq/L • Maintenance therapy • Contraindications
Anticonvulsant Drugs • Valproate (Depakote) • Carbamazepine (Tegretol) • Lamotrigine (Lamictal)
Antianxiety Drugs • Clonazepam (Klonopin) • Lorazepam (Ativan) Atypical Antipsychotics • Olanzapine (Zyprexa) • Risperidone (Risperdal)
Other Treatments • Electroconvulsive therapy (ECT) • Milieu management • Support groups • Health teaching and health promotion
Advanced Practice Interventions • Psychotherapy • Cognitive-behavioral therapy (CBT) • Interpersonal and social rhythm therapy
Evaluation Evaluate outcome criteria Care plan reassessed Care plan revised if indicated